Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

FierceBiotechVedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies

FierceBiotechUniQure stock surges after FDA U-turn clears path to gene therapy filing

PharmaVoiceWhy ivermectin is in the limelight again

Clinical OMICsPhilippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders

LabiotechEight in vivo CAR T biotechs to follow closely

FierceBiotech'Biopharma ecosystem is back to full health,' fueled by M&A: PwC

FierceBiotechJazz, AbCellera strike TCE discovery and development deal worth up to $792M per drug

Endpoints NewsJazz turns to AbCellera for T cell engagers in up to $4.1B partnership

Endpoints NewsSpot Bio launches with $40M to study mRNA therapy for muscular dystrophy

Endpoints NewsTriveni Bio raises $65M ahead of upcoming readouts on eczema drugs

CellCellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology

CellA CRISPR knockout mouse library for functional genomics in influenza research